LIU LIPING,TANG SHIBO,LIANG XIAOLING,LIU Liping,TANG Shibo,LIANG Xiaoling
申请号：
SI201030612
公开号：
SI2470191T1
申请日:
2010.08.23
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention provides methods of preventing or treating ophthalmic diseases or conditions in a mammalian subject, comprising administering to the subject a therapeutically effective amount of an aromatic-cationic peptide represented by the formula D-Arg-2',6'-Dmt-Lys-Phe-NH2 (SS-31) or Phe-D-Arg-Phe-Lys-NH2 (SS-20). The present invention provides methods of preventing or treating ophthalmic diseases or conditions such as diabetic retinopathy, cataracts, retinitis pigmentosa, glaucoma, macular degeneration, choroidal neovascularization, retinal degeneration, and oxygen-induced retinopathy.
